Tilley BC - Search Results

1

A responsive outcome for Parkinson's disease neuroprotection futility studies.

Elm JJ, Goetz CG, Ravina B, Shannon K, Wooten GF, Tanner CM, Palesch YY, Huang P, Guimaraes P, Kamp C, Tilley BC, Kieburtz K; NET-PD Investigators. Elm JJ, et al. Among authors: tilley bc. Ann Neurol. 2005 Feb;57(2):197-203. doi: 10.1002/ana.20361. Ann Neurol. 2005. PMID: 15668964

2

Using global statistical tests in long-term Parkinson's disease clinical trials.

Huang P, Goetz CG, Woolson RF, Tilley B, Kerr D, Palesch Y, Elm J, Ravina B, Bergmann KJ, Kieburtz K; Parkinson Study Group. Huang P, et al. Mov Disord. 2009 Sep 15;24(12):1732-9. doi: 10.1002/mds.22645. Mov Disord. 2009. PMID: 19514076 Free PMC article.

3

Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs.

Tilley BC, Palesch YY, Kieburtz K, Ravina B, Huang P, Elm JJ, Shannon K, Wooten GF, Tanner CM, Goetz GC; NET-PD Investigators. Tilley BC, et al. Neurology. 2006 Mar 14;66(5):628-33. doi: 10.1212/01.wnl.0000201251.33253.fb. Neurology. 2006. PMID: 16534099 Review.

4

Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials.

Guimaraes P, Kieburtz K, Goetz CG, Elm JJ, Palesch YY, Huang P, Ravina B, Tanner CM, Tilley BC. Guimaraes P, et al. Among authors: tilley bc. Clin Trials. 2005;2(6):509-18. doi: 10.1191/1740774505cn125oa. Clin Trials. 2005. PMID: 16422311

5

Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience.

Elm JJ, Kamp C, Tilley BC, Guimaraes P, Fraser D, Deppen P, Brocht A, Weaver C, Bennett S; NINDS NET-PD Investigators and Coordinators. Elm JJ, et al. Among authors: tilley bc. Mov Disord. 2007 Apr 30;22(6):822-7. doi: 10.1002/mds.21409. Mov Disord. 2007. PMID: 17357141 Clinical Trial.

6

Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale.

Seidel SE, Tilley BC, Huang P, Palesch YY, Bergmann KJ, Goetz CG, Swearingen CJ. Seidel SE, et al. Among authors: tilley bc. Parkinsonism Relat Disord. 2012 Mar;18(3):230-3. doi: 10.1016/j.parkreldis.2011.10.006. Epub 2011 Oct 21. Parkinsonism Relat Disord. 2012. PMID: 22018910 Free PMC article.

7

Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease.

Elble RJ, Suchowersky O, Shaftman S, Weiner WJ, Huang P, Tilley B; NINDS NET-PD Investigators. Elble RJ, et al. Mov Disord. 2010 Jun 15;25(8):1082-6. doi: 10.1002/mds.22997. Mov Disord. 2010. PMID: 20131372 Free PMC article.

8

Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.

Elm JJ; NINDS NET-PD Investigators. Elm JJ, et al. Mov Disord. 2012 Oct;27(12):1513-21. doi: 10.1002/mds.25175. Mov Disord. 2012. PMID: 23079770 Free PMC article. Clinical Trial.

9

Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.

Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BC, Shulman LM; NET-PD Investigators. Parashos SA, et al. Among authors: tilley bc. JAMA Neurol. 2014 Jun;71(6):710-6. doi: 10.1001/jamaneurol.2014.391. JAMA Neurol. 2014. PMID: 24711047 Free PMC article. Clinical Trial.

10

Adjusting O'Brien's test to control type I error for the generalized nonparametric Behrens-Fisher problem.

Huang P, Tilley BC, Woolson RF, Lipsitz S. Huang P, et al. Among authors: tilley bc. Biometrics. 2005 Jun;61(2):532-9. doi: 10.1111/j.1541-0420.2005.00322.x. Biometrics. 2005. PMID: 16011701 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

198 results

Search Page

Filters